+1 704-993-8389
Advocacy & Awareness for Immune Disorders Association (AAIDA)
About Us
Mission and Vision
Executive Leadership Team
Our Directors & Team
Story About Us
AAIDA In The News
Advocacy Initiatives
Get Involved
Donate
Get In Touch
Sign Up For Updates
AAIDA Apparel
Immune Disorders
Educational Websites
Educational Articles By Subject
All Educational Articles (Alphabetically)
Autoimmune and Immunosuppressed
COVID-19 & Vaccines
Immune Dysregulation
Immune System Components
IVIG & SCIG
PANDAS
Primary Immunodeficiency (PI)
Federal Healthcare Policy Laws, News & Other Resources
Stories
Programs
Webinars
Events
Donate Now
Autoimmune and Immunosuppressed
Biosimilar Product Information
What You Need to Know About Biosimilar Treatment Options, March 1, 2023
Health Insurance Access Barriers: New National Scorecard, January 26, 2023
Understanding Autoimmune Diseases, June 2022
Analysis of Drug Formulary Exclusions from the Patient’s Perspective, June 2022
What are immunosuppressants?
How T Cells Sense Dangerous Invaders, June 17th, 2021
Emerging Strategies For Treating Autoimmune Disorders With Genetically Modified Treg Cells, January 1st, 2022
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference, June 2021
What Is Sjögren’s Syndrome? Symptoms, Causes, Diagnosis, Treatment, and Prevention, January 28th, 2021
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial, July 2021
Association of Primary Humoral Immunodeficiencies With Psychiatric Disorders and Suicidal Behavior and the Role of Autoimmune Diseases, June 10th, 2020
Mast Cell Activation Syndromes, August, 2017
Ins and Outs of Antibodies, May 2016
Overview of the Immune Response, August 18th, 2010
